MDXXF (Pharmala Biotech Holdings) Liabilities-to-Assets : 0.46 (As of Feb. 2024)

Pharmala Biotech Holdings Liabilities-to-Assets Chart

Pharmala Biotech Holdings Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Liabilities-to-Assets	Get a 7-Day Free Trial							0.31	0.36	0.43	0.37	0.46

Competitive Comparison of Pharmala Biotech Holdings's Liabilities-to-Assets

For the Biotechnology subindustry, Pharmala Biotech Holdings's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmala Biotech Holdings's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmala Biotech Holdings's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Pharmala Biotech Holdings's Liabilities-to-Assets falls into.

Pharmala Biotech Holdings Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Pharmala Biotech Holdings's Liabilities-to-Assets Ratio for the fiscal year that ended in Aug. 2023 is calculated as:

Pharmala Biotech Holdings's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings  (OTCPK:MDXXF) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Pharmala Biotech Holdings Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description